Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute Kidney Injury and BK Polyomavirus in Urine Sediment Cells.
Pajenda S, Gerges DA, Freire R, Wagner L, Hevesi Z, Aiad M, Eder M, Schmidt A, Winnicki W, Eskandary FA. Pajenda S, et al. Among authors: gerges da. Int J Mol Sci. 2023 Dec 15;24(24):17511. doi: 10.3390/ijms242417511. Int J Mol Sci. 2023. PMID: 38139342 Free PMC article.
Frequency and mutational spectrum of PIK3CA gene mutations in breast cancer patients: Largest and first report from Lebanon.
Hamadeh LN, Farhat L, Hilal L, Assi H, Nasr F, Chahine G, Kattan J, Farhat F, Kourie H, El Hachem G, Ghosn M, El Saghir N, Chamseddine N, Finianos A, Ghanem H, Younes A, Gerges DA, Temraz S, Haidar M, Nabhan T, Chamseddine A, Tfayli A, Zaatari G, Mahfouz R. Hamadeh LN, et al. Among authors: gerges da. Gene. 2023 Jun 30;871:147433. doi: 10.1016/j.gene.2023.147433. Epub 2023 Apr 15. Gene. 2023. PMID: 37068694
Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2.
Hevesi Z, Gerges DA, Kapps S, Freire R, Schmidt S, Pollak DD, Schmetterer K, Frey T, Lang R, Winnicki W, Schmidt A, Harkany T, Wagner L. Hevesi Z, et al. Among authors: gerges da. Vaccines (Basel). 2022 Mar 26;10(4):516. doi: 10.3390/vaccines10040516. Vaccines (Basel). 2022. PMID: 35455265 Free PMC article.
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG).
Tomova A, Bartsch R, Brodowicz T, Tzekova V, Timcheva C, Wiltschke C, Gerges DA, Pawlega J, Spanik S, Inbar M, Zielinski CC. Tomova A, et al. Among authors: gerges da. Breast Cancer Res Treat. 2010 Jan;119(1):169-76. doi: 10.1007/s10549-009-0553-4. Breast Cancer Res Treat. 2010. PMID: 19768533 Clinical Trial.